Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Toronto
- Most recent report
- 6-K, filed Nov 6, 2026
- Incorporated
- N/A
- Filings on record
- 453 filings
- On EDGAR
- CIK 1833141
- Fiscal year ends
- March
- Filer status
- Emerging growth company
Financials 8 of 310
- 6-K Report a foreign issuer made public elsewhere Nov 6, 2026
- 6-K Report a foreign issuer made public elsewhere Nov 3, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 27, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 21, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 15, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 8, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 5, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 2, 2026
Prospectuses and Registrations 6
Ownership 8 of 55
- 3 Insider reported their initial holding Nov 2, 2026
- 3 Insider reported their initial holding Oct 26, 2026
- 3 Insider reported their initial holding Oct 26, 2026
- 3 Insider reported their initial holding Oct 23, 2026
- 3 Insider reported their initial holding Oct 23, 2026
- 3 Insider reported their initial holding Oct 23, 2026
- 3 Insider reported their initial holding Oct 23, 2026
- 4 Insider reported a trade Oct 1, 2026
Other 8 of 82
Everything here comes from Helus Pharma Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.